BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang T, Nie Y, Xia H, Zhang Y, Cai K, Chen X, Li H, Wang J. Identification of Immune-Related Prognostic Genes and LncRNAs Biomarkers Associated With Osteosarcoma Microenvironment. Front Oncol 2020;10:1109. [PMID: 32793475 DOI: 10.3389/fonc.2020.01109] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Liu H, Chen C, Liu L, Wang Z. A four-lncRNA risk signature for prognostic prediction of osteosarcoma. Front Genet 2022;13:1081478. [PMID: 36685868 DOI: 10.3389/fgene.2022.1081478] [Reference Citation Analysis]
2 Du QC, Wang XY, Hu CK, Zhou L, Fu Z, Liu S, Wang J, Ma YY, Liu MY, Yu H. Integrative analysis of platelet-related genes for the prognosis of esophageal cancer. World J Clin Cases 2022; 10(33): 12077-12088 [DOI: 10.12998/wjcc.v10.i33.12077] [Reference Citation Analysis]
3 Huang W, Xiao Y, Wang H, Chen G, Li K. Identification of risk model based on glycolysis-related genes in the metastasis of osteosarcoma. Front Endocrinol 2022;13. [DOI: 10.3389/fendo.2022.1047433] [Reference Citation Analysis]
4 Wang J, Jin J, Liang Y, Zhang Y, Wu N, Fan M, Zeng F, Deng F. miR-21-5p/PRKCE axis implicated in immune infiltration and poor prognosis of kidney renal clear cell carcinoma. Front Genet 2022;13:978840. [DOI: 10.3389/fgene.2022.978840] [Reference Citation Analysis]
5 Shen Z, Li X, Hu Z, Yang Y, Yang Z, Li S, Zhou Y, Ma J, Li H, Liu X, Cai J, Pu L, Wang X, Huang Y. Linc00996 is a favorable prognostic factor in LUAD: Results from bioinformatics analysis and experimental validation. Front Genet 2022;13:932973. [DOI: 10.3389/fgene.2022.932973] [Reference Citation Analysis]
6 Fu R, Hong X, Shen Y. Discovery of New Therapeutic Targets for Osteosarcoma Treatment Based on Immune-Related lncRNAs in the Tumor Microenvironment. BioMed Research International 2022;2022:1-13. [DOI: 10.1155/2022/3113857] [Reference Citation Analysis]
7 Wang Q, Zhang W, Guo Y, Li Y, Fu K. Development of an immune-related signature for predicting survival outcome and immunotherapy response in osteosarcoma. Aging (Albany NY) 2021;13:24155-70. [PMID: 34747719 DOI: 10.18632/aging.203671] [Reference Citation Analysis]
8 Tan P, Chen H, Huang Z, Huang M, Du Y, Li T, Chen Z, Liu Y, Fu W. MMP25-AS1/hsa-miR-10a-5p/SERPINE1 axis as a novel prognostic biomarker associated with immune cell infiltration in KIRC. Mol Ther Oncolytics 2021;22:307-25. [PMID: 34553021 DOI: 10.1016/j.omto.2021.07.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
9 Cascini C, Chiodoni C. The Immune Landscape of Osteosarcoma: Implications for Prognosis and Treatment Response. Cells 2021;10:1668. [PMID: 34359840 DOI: 10.3390/cells10071668] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
10 Le T, Su S, Shahriyari L. Immune classification of osteosarcoma. Math Biosci Eng 2021;18:1879-97. [PMID: 33757216 DOI: 10.3934/mbe.2021098] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]